Clinical Trials Browser

Phase 3 × Terminated × Rivaroxaban × Clear all

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thromboembolism